Find News

Filter articles

Applied Filters

Showing 61 to 70 of 847 results

Bausch Health resolves IP litigation with Teva

US02-08-2019Sarah Morgan

Canadian pharmaceutical company Bausch Health and generics maker Teva have resolved their dispute over Apriso (mesalazine), a drug used to treat ulcerative colitis and Crohn's disease. 

Alkermes settles with Amneal over opioid dependence treatment

US31-07-2019Sarah Morgan

Biopharmaceutical company Alkermes has entered into a settlement and licence agreement with generic maker Amneal Pharmaceuticals to resolve an inter partes review.

Teva to pay California $69m over pay-for-delay deals

US30-07-2019Saman Javed

The state of California has secured a $69 million settlement with Teva, which allegedly entered into collusive pay-for-delay agreements with generic competitors.

Pfizer off-patent division to merge with Mylan

UK29-07-2019Rory O'Neill

Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

Celgene settles antitrust class-action for $55m

US25-07-2019Saman Javed

US biotech company Celgene has agreed to pay a $55 million settlement after it was accused of illegally maintaining a monopoly over the market for its cancer treatments.

FDA opens US to Lyrica generics

US24-07-2019Sarah Morgan

The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica.

Endo pays $2.3m to settle states antitrust claims

US22-07-2019Sarah Morgan

Ireland-headquartered Endo Pharmaceuticals agreed to pay $2.3 million to 18 states late last week, settling allegations that the drugmaker paid a competitor to keep a generic version of pain relief drug Lidoderm off the market.

Johnson & Johnson braces for Q3 sales dip as generics bite

US18-07-2019Saman Javed

Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.

Delhi court rejects Bayer injunction against Natco Pharma generic

India18-07-2019Saman Javed

India’s Delhi High Court has dismissed a petition for an injunction by German pharma company Bayer against an Indian competitor.

Indivior appeal fails to stop generic opioid addiction challenge

US15-07-2019Saman Javed

The US Court of Appeals for the Federal Circuit has upheld an earlier ruling that Indivior cannot stop two competitors from making a generic version of one of its drugs.

Showing 61 to 70 of 847 results